Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May:199:115015.
doi: 10.1016/j.bcp.2022.115015. Epub 2022 Apr 5.

Obesity II: Establishing causal links between chemical exposures and obesity

Affiliations
Review

Obesity II: Establishing causal links between chemical exposures and obesity

Jerrold J Heindel et al. Biochem Pharmacol. 2022 May.

Erratum in

  • Corrigendum to "Obesity II: Establishing causal links between chemical exposures and obesity" [Biochem. Pharmacol. 199 (2022) 115015].
    Heindel JJ, Howard S, Agay-Shay K, Arrebola JP, Audouze K, Babin PJ, Barouki R, Bansal A, Blanc E, Cave MC, Chatterjee S, Chevalier N, Choudhury M, Collier D, Connolly L, Coumoul X, Garruti G, Gilbertson M, Hoepner LA, Holloway AC, Howell G 3rd, Kassotis CD, Kay MK, Kim MJ, Lagadic-Gossmann D, Langouet S, Legrand A, Li Z, Le Mentec H, Lind L, Lind PM, Lustig RH, Martin-Chouly C, Munic Kos V, Podechard N, Roepke TA, Sargis RM, Starling A, Tomlinson CR, Touma C, Vondracek J, Vom Saal F, Blumberg B. Heindel JJ, et al. Biochem Pharmacol. 2022 Aug;202:115144. doi: 10.1016/j.bcp.2022.115144. Epub 2022 Jun 14. Biochem Pharmacol. 2022. PMID: 35714447 No abstract available.

Abstract

Obesity is a multifactorial disease with both genetic and environmental components. The prevailing view is that obesity results from an imbalance between energy intake and expenditure caused by overeating and insufficient exercise. We describe another environmental element that can alter the balance between energy intake and energy expenditure: obesogens. Obesogens are a subset of environmental chemicals that act as endocrine disruptors affecting metabolic endpoints. The obesogen hypothesis posits that exposure to endocrine disruptors and other chemicals can alter the development and function of the adipose tissue, liver, pancreas, gastrointestinal tract, and brain, thus changing the set point for control of metabolism. Obesogens can determine how much food is needed to maintain homeostasis and thereby increase the susceptibility to obesity. The most sensitive time for obesogen action is in utero and early childhood, in part via epigenetic programming that can be transmitted to future generations. This review explores the evidence supporting the obesogen hypothesis and highlights knowledge gaps that have prevented widespread acceptance as a contributor to the obesity pandemic. Critically, the obesogen hypothesis changes the narrative from curing obesity to preventing obesity.

Keywords: Adipocyte differentiation; Endocrine disruptor; Obesity; Obesogen; Weight gain.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.. Sources of obesogens.
This figure shows just some of the major classes of obesogens along with some sources of exposure. Exposure to obesogens occurs at home and work; via the air, water, food and skin contact.
Fig. 2.
Fig. 2.. Epigenetic regulation of obesity
Chemicals shown are just representatives of all of the classes of chemicals that are obesogens, and that can act via alterations in epigenetic control of gene expression, especially when exposures occur during development when hormones and growth factors are controlling cell and tissue differentiation. The known epigenetic control systems are shown: DNA methylation, Histone modification, chromatin modeling, and a variety of noncoding RNAs.
Fig. 3.
Fig. 3.. BPA regulation of obesity
BPA is an obesogen. The actions of BPA are the most detailed and comprehensive of all obesogens and this figure indicates the multiple sites and mechanisms whereby it was shown to act to stimulate weight gain from in vitro and animal model experiments.
Fig. 4.
Fig. 4.. Classification of nutritive and non-nutritive sweeteners.
There are a variety of nutritive and non-nutritive sweeteners. This classification scheme shows the different categories and where each nutritive and non-nutritive fall to help in understanding their chemical backbone and chemistry.
Fig. 5.
Fig. 5.. Multiple actions of obesogens.
Obesogens in addition to increasing the number and size of adipocytes also affect other tissues and process. Several of the main effects of obesogens are shown here. These are not all of the tissues and processes affected but show the broad effects of obesogenic chemicals. The chemicals shown have been reported to have that effect but that does not mean that other chemicals may not also have those effects. For example, the three chemicals shown are the only ones that have been examined for their effects on pathways and genes in adipocytes. It may be that other obesogens will also stimulate the production of dysfunctional adipocytes. Colors are only to highlight the same chemical across multiple mechanisms.
Fig. 6.
Fig. 6.. Composite of sites and mechanisms of obesogens.
Obesogens, as described in the text, can act via a variety of mechanisms and act on a variety of tissues. Some mechanisms are direct, such as receptor mechanisms and epigenetic changes and some, such as sirtuins, oxidative stress, inflammation, circadian rhythms, alterations in food intake and food addiction, and increase in number and size of fat cells, can result from the initial mechanisms. Obesogens have both direct and indirect actions on several tissues like liver, pancreas, muscle, gut microbiome, and brain. Thus, obesogens can disrupt all the sites and tissues known to be involved in control of metabolism.

References

    1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet 384 (9945) (2014) 766–781. - PMC - PubMed
    1. Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, Leibel RL, Obesity Pathogenesis: An Endocrine Society Scientific Statement, Endocr. Rev 38 (4) (2017) 267–296. - PMC - PubMed
    1. Blüher M, Obesity: global epidemiology and pathogenesis, Nat. Rev. Endocrinol 15 (5) (2019) 288–298. - PubMed
    1. Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB, Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem, Current obesity reports 4 (3) (2015) 363–370. - PubMed
    1. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society, Endocrinology 153 (2012). - PMC - PubMed

Publication types

Substances